
Please try another search
Homology Medicines, Inc. is a clinical-stage genetic medicines company focused on providing treatment for rare genetic diseases. The Company’s clinical programs include HMI-102, is an investigational gene therapy candidate in clinical development for the treatment of adult patients with phenylketonuria (PKU); HMI-103, which is an investigational gene editing candidate in clinical development for the treatment of patients with PKU, and HMI-203, which is an investigational gene therapy candidate in clinical development for the treatment of patients with mucopolysaccharidosis type II (MPS II), or Hunter syndrome. Additionally, the Company is developing a gene therapy candidate, HMI-104, from its GTx-mAb platform for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH), and conducting research in other diseases, including metachromatic leukodystrophy (MLD). Its platform is designed to utilize human hematopoietic stem cell derived adeno-associated virus vectors.
Name | Age | Since | Title |
---|---|---|---|
Saswati Chatterjee | - | - | Co-Founder & Member of Scientific Advisory Board |
Stephen J. Elledge | - | - | Member of Scientific Advisory Board |
Hans-Peter Kiem | - | - | Member of Scientific Advisory Board |
Morton J. Cowan | - | - | Member of Scientific Advisory Board |
Jeffrey V. Poulton | 54 | 2020 | Independent Director |
Alise S. Reicin | 61 | 2019 | Independent Director |
Richard James Gregory | 64 | 2015 | Independent Director |
Albert Seymour | 54 | 2016 | Chief Executive Officer, President & Director |
Mason W. Freeman | 71 | - | Member of Scientific Advisory Board |
Beverly L. Davidson | - | 2018 | Chairman of Scientific Advisory Board |
Arthur O. Tzianabos | 59 | 2016 | Chairman of the Board |
Steven S. Gillis | 69 | 2016 | Independent Director |
Mary T. Thistle | 62 | 2018 | Independent Director |
Matthew R. Patterson | 50 | 2018 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review